tiprankstipranks
Advertisement

SPEU - ETF AI Analysis

Compare

Top Page

SPEU

SPDR Portfolio Europe ETF (SPEU)

Rating:63Neutral
Price Target:
SPEU, the SPDR Portfolio Europe ETF, earns a solid overall rating driven mainly by strong, diversified European leaders like HSBC, Novartis, and AstraZeneca, which show robust financial performance, positive earnings sentiment, and generally supportive technical trends. Some holdings such as Roche, Shell, and Allianz introduce caution due to valuation concerns, overbought or bearish technical signals, and growth or leverage challenges. The main risk factor is the fund’s concentration in European markets and large regional financial and pharmaceutical names, which can make performance sensitive to sector-specific and regional economic conditions.
Positive Factors
Strong Recent Performance
The ETF has delivered steady gains over the past month, three months, and year to date, showing solid recent momentum.
Leading European Blue-Chip Holdings
Top positions like ASML, HSBC, and several major healthcare and consumer companies have shown strong or steady performance, helping support the fund’s returns.
Low Expense Ratio
The fund’s relatively low annual fee means more of the investment’s growth can stay in investors’ pockets over time.
Negative Factors
Heavy Europe Focus
With most assets in European markets, the ETF is heavily exposed to economic and political developments in Europe, which may limit diversification for investors already holding U.S. or global funds.
Concentrated Country Exposure
Large weights in the UK, France, and Germany mean the fund’s performance is strongly tied to just a few European economies.
Mixed Performance Among Top Holdings
While several major positions have performed well, at least one large holding has shown weak results, which can drag on overall returns if that continues.

SPEU vs. SPDR S&P 500 ETF (SPY)

SPEU Summary

SPEU is the SPDR Portfolio Europe ETF, which follows the STOXX Europe Total Market Index. It gives you broad exposure to European stocks across many countries and industries in a single investment. The fund holds well-known companies like Nestlé, HSBC, and Shell, so you’re getting a mix of consumer, financial, and energy businesses. Someone might invest in SPEU to diversify beyond the U.S. and tap into Europe’s long-term growth potential. A key risk is that European stock prices can rise or fall with the overall market and regional economic conditions.
How much will it cost me?The SPDR Portfolio Europe ETF (SPEU) has an expense ratio of 0.07%, meaning you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically involves fewer costs compared to actively managed funds.
What would affect this ETF?The SPDR Portfolio Europe ETF (SPEU) could benefit from positive economic growth in Europe, particularly in sectors like financials, industrials, and healthcare, which make up a significant portion of its holdings. However, challenges such as rising interest rates, regulatory changes, or economic slowdowns in developed European markets could negatively impact the ETF's performance. Additionally, fluctuations in the performance of top holdings like ASML, Nestlé, and AstraZeneca may influence the fund's returns.

SPEU Top 10 Holdings

SPEU leans heavily on a mix of European heavyweights, with ASML acting as a key engine for longer-term gains despite some recent wobbling. Big banks like HSBC and Banco Santander have been rising, giving the fund a financial backbone that’s helped performance. On the defensive side, pharma names Roche and Novartis are steady contributors, while AstraZeneca has been losing steam and Nestlé’s consumer staples strength has been more muted. Overall, the ETF is broadly diversified across sectors, but firmly anchored in developed European markets.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV4.25%$30.24M€597.04B127.48%
76
Outperform
HSBC Holdings2.19%$15.58M£266.83B61.62%
80
Outperform
Roche Holding AG1.88%$13.37M$345.58B34.54%
73
Outperform
Novartis AG1.82%$12.95MCHF231.67B37.69%
80
Outperform
AstraZeneca1.61%$11.47M$261.19B19.44%
80
Outperform
Nestlé SA1.57%$11.14MCHF207.50B6.66%
71
Outperform
Shell (UK)1.52%$10.81M£183.16B21.96%
73
Outperform
Siemens1.40%$9.96M€207.53B21.64%
74
Outperform
Banco Santander1.23%$8.76M€175.79B59.08%
73
Outperform
TotalEnergies SE1.21%$8.61M€169.42B35.70%
78
Outperform

SPEU Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
54.52
Positive
100DMA
53.29
Positive
200DMA
52.14
Positive
Market Momentum
MACD
RSI
STOCH
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 54.94, equal to the 50-day MA of 54.52, and equal to the 200-day MA of 52.14, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPEU.

SPEU Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$713.95M0.07%
63
Neutral
$29.72B0.06%
61
Neutral
$9.40B0.50%
63
Neutral
$765.17M0.45%
63
Neutral
$118.51M0.25%
63
Neutral
$116.06M0.09%
63
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SPEU
SPDR Portfolio Europe ETF
55.08
8.96
19.43%
VGK
Vanguard FTSE Europe ETF
EZU
iShares MSCI Eurozone ETF
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
FLEE
Franklin FTSE Europe ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement